tiprankstipranks
Trending News
More News >
Sana Biotechnology, Inc. (SANA)
:SANA
US Market

Sana Biotechnology (SANA) Stock Statistics & Valuation Metrics

Compare
581 Followers

Total Valuation

Sana Biotechnology has a market cap or net worth of $568.40M. The enterprise value is $6.54B.
Market Cap$568.40M
Enterprise Value$6.54B

Share Statistics

Sana Biotechnology has 225,555,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding225,555,370
Owned by Insiders
Owned by Institutions

Financial Efficiency

Sana Biotechnology’s return on equity (ROE) is -1.06 and return on invested capital (ROIC) is -58.26%.
Return on Equity (ROE)-1.06
Return on Assets (ROA)-0.53
Return on Invested Capital (ROIC)-58.26%
Return on Capital Employed (ROCE)-0.60
Revenue Per Employee0.00
Profits Per Employee-1.38M
Employee Count194
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Sana Biotechnology is -1.41. Sana Biotechnology’s PEG ratio is -0.06.
PE Ratio-1.41
PS Ratio0.00
PB Ratio-46.13
Price to Fair Value1.50
Price to FCF-58.88
Price to Operating Cash Flow-76.90
PEG Ratio-0.06

Income Statement

In the last 12 months, Sana Biotechnology had revenue of 0.00 and earned -266.76M in profits. Earnings per share was -1.16.
Revenue0.00
Gross Profit0.00
Operating Income-272.72M
Pretax Income-266.76M
Net Income-266.76M
EBITDA-251.27M
Earnings Per Share (EPS)-1.16

Cash Flow

In the last 12 months, operating cash flow was -206.18M and capital expenditures -17.72M, giving a free cash flow of -223.90M billion.
Operating Cash Flow-206.18M
Free Cash Flow-223.90M
Free Cash Flow per Share-0.99

Dividends & Yields

Sana Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.21
52-Week Price Change-46.27%
50-Day Moving Average1.99
200-Day Moving Average2.84
Relative Strength Index (RSI)64.93
Average Volume (3m)3.74M

Important Dates

Sana Biotechnology upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend Date

Financial Position

Sana Biotechnology as a current ratio of 3.54, with Debt / Equity ratio of -33.82%
Current Ratio3.54
Quick Ratio3.54
Debt to Market Cap0.03
Net Debt to EBITDA0.13
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Sana Biotechnology has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Sana Biotechnology EV to EBITDA ratio is -1.37, with an EV/FCF ratio of -1.34.
EV to Sales0.00
EV to EBITDA-1.37
EV to Free Cash Flow-1.34
EV to Operating Cash Flow-1.54

Balance Sheet

Sana Biotechnology has $104.70M in cash and marketable securities with $91.31M in debt, giving a net cash position of -$13.39M billion.
Cash & Marketable Securities$104.70M
Total Debt$91.31M
Net Cash-$13.39M
Net Cash Per Share-$0.06
Tangible Book Value Per Share$0.22

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Sana Biotechnology is $7.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$7.33
Price Target Upside160.85% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast
EPS Growth Forecast19.94%

Scores

Smart Score5
AI Score33
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis